Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?

Cannabidiol (CBD)-containing products are widely marketed as over the counter products. Adverse effects reported in anecdotal consumer reports or during clinical studies were first assumed to be due to acid-catalysed cyclization of CBD to psychotropic Δ (9)-tetrahydrocannabinol (Δ (9)-THC) in the st...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:F1000Res
Auteurs principaux: Lachenmeier, Dirk W., Habel, Stephanie, Fischer, Berit, Herbi, Frauke, Zerbe, Yvonne, Bock, Verena, Rajcic de Rezende, Tabata, Walch, Stephan G., Sproll, Constanze
Format: Artigo
Langue:Inglês
Publié: F1000 Research Limited 2024
Sujets:
Brief Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7029751/
https://ncbi.nlm.nih.gov/pubmed/32117565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.19931.7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires